Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
24 March, 2018 08:08 IST
Zydus Cadila gets USFDA's final nod for Tizanidine tablets
Source: IRIS | 13 Mar, 2018, 11.05AM
Comments  |  Post Comment

Zydus Cadila has received the final approval from the USFDA to market Tizanidine Tablets USP in the strengths of 2 mg and 4 mg.

The drug is used to treat muscle spasms caused by certain conditions such as multiple sclerosis, spinal cord injury and works by helping to relax the muscles.

It will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.

The group now has more than 180 approvals and has so far filed over 320 ANDAs since the commencement of the filing process in FY 2003-04.

Shares of the company gained Rs 11.3, or 2.94%, to trade at  Rs 395.10.  The total volume of shares traded  was  24,840 at the BSE (10.47 a.m., Tuesday).

Cadila Healthcare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Security Code type    into this box
Related Articles
Sensex ends 409 points lower; Nifty settles below 10,000 - 23-Mar-2018 16:09
Tata Steel identified as successful resolution application for acquisition of Bhushan Steel - 23-Mar-2018 12:36
Vakrangee ties up with Blue Dart Express - 23-Mar-2018 09:54
Sensex tumbles over 400 points; Nifty below 10,000 - 23-Mar-2018 09:48
Sensex ends 130 points lower; Nifty settles below 10,150 - 22-Mar-2018 16:02
Suven Life Sciences secures 3 overseas product patents - 22-Mar-2018 12:24
Cox & Kings sells 11.58% stake in subsidiary - 22-Mar-2018 12:20
Sadbhav Infra receives LoA for NHAI road project - 22-Mar-2018 10:44
Steel Strips Wheels receives 7,000 wheel order from UK aftermarket - 22-Mar-2018 10:37
Zensar Technologies acquires US based Cynosure Inc - 22-Mar-2018 10:33
Dilip Buildcon declared L-1 bidder for Rs 6.77 bn NHAI project - 22-Mar-2018 10:26
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer